UT SOUTHWESTERN MONCRIEF CANCER CENTER MONCRIEF CANCER INSTITUTE

EIN: 752655008 501(c)(3) Diseases & Disorders

FORT WORTH, TX

Total Revenue
$14,022,142
Total Expenses
$14,501,991
Total Assets
$37,055,714
Net Assets
$29,095,478
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1958
Legal Domicile
TX
Principal Officer
HOLLY CRAWFORD
Phone
8172889800
Tax Period
2023-09-01 to 2024-08-31

UT SOUTHWESTERN MONCRIEF CANCER CENTER MONCRIEF CANCER INSTITUTE, founded in 1958, is a mid-sized nonprofit in the Diseases & Disorders sector that reported $14.0M in total revenue in fiscal year 2023. Revenue grew 14% year-over-year, indicating healthy expansion. Net assets of $29.1M represent 25 months of operating reserves.

Mission

TO BE A LEADER IN OUR COMMUNITY'S EFFORTS TO FIGHT CANCER AND REDUCE ITS BURDEN THROUGHOUT THE CONTINUUM OF CARE SETTING, USING EDUCATION, AWARENESS, PREVENTION, EARLY DETECTION, BEHAVIORAL AND NUTRITIONAL SCIENCES AND RESEARCH.

Program Service Accomplishments

Program 1
Expenses: $4,801,820

MONCRIEF CANCER INSTITUTE'S BREAST AND CERVICAL CANCER SCREENING PROGRAM OFFERS FREE MAMMOGRAMS, CLINICAL BREAST EXAMS, AND PAP/HPV CO-TESTS TO UNDERSERVED/UNINSURED WOMEN. THE PROGRAM ENSURES...

Read more

MONCRIEF CANCER INSTITUTE'S BREAST AND CERVICAL CANCER SCREENING PROGRAM OFFERS FREE MAMMOGRAMS, CLINICAL BREAST EXAMS, AND PAP/HPV CO-TESTS TO UNDERSERVED/UNINSURED WOMEN. THE PROGRAM ENSURES PATIENTS WITH LIMITED ACCESS CAN OBTAIN THE RECOMMENDED SCREENINGS. THROUGH OUR COMPREHENSIVE PATIENT NAVIGATION PROCESS, PATIENTS WITH POSITIVE FINDINGS ARE NAVIGATED TO OBTAIN FURTHER STUDIES AND THERAPEUTIC OPTIONS SHOULD THEY BE REQUIRED. IN THE PAST YEAR, THE PROGRAM PROVIDED MORE THAN 10,500 BREAST CANCER SCREENINGS AND DIAGNOSTICS AND NEARLY 1,500 CERVICAL CANCER SCREENINGS AND DIAGNOSTICS.

Program 2
Expenses: $4,514,773

ORIGINALLY A RADIATION THERAPY CENTER, MONCRIEF CANCER INSTITUTE HAS EVOLVED INTO A PROVIDER OF SERVICES DESIGNED TO REDUCE THE BURDEN OF CANCER AND REMOVE BARRIERS TO CARE THROUGH PREVENTION...

Read more

ORIGINALLY A RADIATION THERAPY CENTER, MONCRIEF CANCER INSTITUTE HAS EVOLVED INTO A PROVIDER OF SERVICES DESIGNED TO REDUCE THE BURDEN OF CANCER AND REMOVE BARRIERS TO CARE THROUGH PREVENTION, SURVIVORSHIP, AND RESEARCH. THESE SERVICES INCLUDE PUBLIC EDUCATION, PREVENTION/EARLY DETECTION, GENETIC SCREENING AND COUNSELING, FINANCIAL ADVOCACY, MULTIDISCIPLINARY SURVIVORSHIP SERVICES, AND POPULATION RESEARCH. AS A RESULT, MONCRIEF CANCER INSTITUTE PROVIDES FREE CANCER SCREENING SERVICES TO THOSE WHO OTHERWISE WOULDN'T HAVE ACCESS. MONCRIEF DETECTS CANCERS AT EARLIER, MORE TREATABLE STAGES, HELPS PATIENTS OBTAIN ACCESS TO TREATMENT, AND AIDS CANCER SURVIVORS IN RESUMING ACTIVE LIFESTYLES. DELIVERING CARE IN MORE THAN 100 NORTH, EAST, AND CENTRAL TEXAS COUNTIES, AT A PHYSICAL FORT WORTH LOCATION, WITHIN PARTNER CLINICS, AND ABOARD TWO MOBILE SCREENING CLINICS, MONCRIEF CANCER INSTITUTE'S IMPLEMENTATION OF THESE SERVICES SUPPORTS ITS CONTINUED MISSION OF EASING THE BURDEN OF CANCER THROUGHOUT THE CONTINUUM OF CARE.

Program 3
Expenses: $849,444

MONCRIEF CANCER INSTITUTE'S COLORECTAL CANCER SCREENING PROGRAM IS FREE FOR INDIVIDUALS WHO ARE UNDERSERVED/UNINSURED AND MEET THE CLINICAL ELIGIBILITY REQUIREMENTS. PATIENTS ARE MAILED AN AT-HOME...

Read more

MONCRIEF CANCER INSTITUTE'S COLORECTAL CANCER SCREENING PROGRAM IS FREE FOR INDIVIDUALS WHO ARE UNDERSERVED/UNINSURED AND MEET THE CLINICAL ELIGIBILITY REQUIREMENTS. PATIENTS ARE MAILED AN AT-HOME COLORECTAL CANCER SCREENING TEST. PATIENTS WITH POSITIVE FINDINGS ARE NAVIGATED TO OBTAIN A COLONOSCOPY. MONCRIEF PARTNERS WITH HOSPITALS, CLINICS, AND HEALTHCARE PROVIDERS IN 87 COUNTIES ACROSS NORTH AND EAST TEXAS TO PERFORM DIAGNOSTIC COLONOSCOPIES. OVER THE PAST YEAR, MORE THAN 5,700 PATIENTS COMPLETED AT-HOME COLORECTAL CANCER SCREENING TESTS, AND OVER 180 PATIENTS HAD COLONOSCOPIES COMPLETED.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $10,993,960
Program Service Revenue $0
Investment Income $252,225
Other Revenue $2,775,957
TOTAL REVENUE $14,022,142

Expense Breakdown

Grants Paid $82,353
Salaries & Benefits $0
Fundraising Expenses $152,571
Program Expenses $11,738,636
Other Expenses $14,419,638
TOTAL EXPENSES $14,501,991

Year-over-Year Comparison

2023 2022 Change
Revenue $14,022,142 $12,312,865 +0.1%
Expenses $14,501,991 $13,182,648 +0.1%
Net Income $-479,849 $-869,783 -0.4%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
4
Independent Members
1
Employees
N/A
Volunteers
5

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
4
$2,284,502
Total Directors
5
$3,250,379
Key Employees
1
$508,073
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
MACK MITCHELL MD CHAIRMAN/PRESIDENT 40.00
Officer Director
$0 $44,226 $717,369
KIT MONCRIEF DIRECTOR 1.00
Director
$0 $0 $0
HOLLY CRAWFORD TREASURER 40.00
Officer Director
$0 $44,226 $1,037,642
CARLOS LUIS ARTEAGA MD DIRECTOR 40.00
Director
$0 $78,679 $965,877
MICHAEL SERBER SECRETARY & ASSIST. TREASURER 40.00
Officer Director
$0 $50,503 $529,491
DANIEL K PODOLSKY MD PRESIDENT OF UT SOUTHWESTERN 0.00
Officer
$0 $0 $0
KEITH E ARGENBRIGHT MD DIRECTOR 40.00
Key Emp
$0 $44,226 $508,073
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 No data No data No data No data
2024 $14,022,142 $14,501,991 $37,055,714 $-479,849
2023 $12,312,865 $13,182,648 $38,490,758 $-869,783
2022 $10,808,694 $12,104,484 $41,907,777 $-1,295,790
2021 $10,388,679 $11,863,912 $34,033,245 $-1,475,233
2020 $10,699,350 $11,878,158 $36,027,544 $-1,178,808
2019 $12,458,154 $13,542,781 $36,374,478 $-1,084,627
2018 $12,661,893 $13,761,692 $37,935,781 $-1,099,799
Explore More Nonprofits
Top 100 Nonprofits in Texas Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare UT SOUTHWESTERN MONCRIEF CANCER CENTER MONCRIEF CANCER INSTITUTE with other nonprofits in Texas and across the country.